Regeneron's Inmazeb Approval For Ebola Paves The Way In COVID-19
Executive Summary
The US FDA approved the first antibody cocktail for ebolavirus infection, supporting a supply contract with BARDA. The development experience informed Regeneron's work in COVID-19.